Long-term outcome of sporadic and FAP-associated desmoid tumors treated with high-dose selective estrogen receptor modulators and sulindac: a single-center long-term observational study in 134 patients
Crossref DOI link: https://doi.org/10.1007/s10689-015-9830-z
Published Online: 2015-08-15
Published Print: 2016-01
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Quast, Daniel Robert
Schneider, Ralph
Burdzik, Emanuel
Hoppe, Steffen
Möslein, Gabriela
Text and Data Mining valid from 2015-08-15